15 Frequently Asked Questions — Leukemia, Lymphoma and Blood Cancer Treatments in India for Australian Patients

Q1 · Why Do Australian Patients Consider Leukemia, Lymphoma and Blood Cancer Treatment in India?

Australian patients may consider India for blood cancer treatment because of specialist haematology expertise, large cancer hospitals, multidisciplinary teams, advanced laboratory facilities and potentially lower private-treatment costs.

Reasons patients may consider India include:

• Experienced haematologists and haemato-oncologists
• Large multispecialty and dedicated cancer hospitals
• Multidisciplinary blood cancer teams
• Advanced pathology and molecular testing
• Chemotherapy and immunotherapy facilities
• Targeted cancer therapies for selected patients
• CAR-T cell therapy availability for selected blood cancers
• Stem-cell and bone-marrow transplantation programmes
• Blood-bank and transfusion support
• Radiation oncology facilities
• Potentially shorter waiting periods for selected planned treatments
• Competitive treatment costs compared with some private healthcare options
• International-patient services in major Indian medical cities
• Supportive care, nutrition and rehabilitation services

Important Cost should not be the only factor. Patients should research the haematologist, hospital, exact blood cancer diagnosis, treatment protocol and long-term follow-up plan carefully and discuss overseas treatment with an Australian healthcare professional before travelling.

Q2 · How Much Does Leukemia, Lymphoma and Blood Cancer Treatment Cost in India for Australian Patients?

The cost of blood cancer treatment varies significantly according to the type of cancer, stage or risk group, treatment protocol, medicines, number of cycles, hospital, complications, ICU requirements, molecular testing and whether stem-cell transplantation or cellular therapy is required.

Australian patients should compare the complete treatment cost rather than looking only at the treatment or chemotherapy fee.

For Easy Comparison, Costs are mentioned in US Dollars (USD), Indian Rupees (INR) and Australian Dollar (AUD)

Exchange Rate Used for Planning

A$1 ≈ US$0.65  •  US$1 = ₹95

USD conversions are approximate and exchange rates change regularly. These are planning ranges rather than guaranteed hospital quotations. Australian costs vary according to the private hospital, haematologist, insurance arrangements and individual circumstances. Indian costs vary according to the hospital, haematologist, medicines, treatment protocol, transplant requirements, room category, technology and package inclusions.

What Should Be Included in the Total Cost?

Ask whether the quotation includes:

• Haematologist/oncologist fees
• Hospital charges
• Day-care or inpatient treatment
• Chemotherapy medicines
• Immunotherapy or targeted medicines
• Stem-cell collection where applicable
• Transplant-related charges where applicable
• Donor testing where applicable
• Blood and platelet transfusions
• Pathology and molecular testing
• Imaging
• ICU care where required
• Medicines
• Infection management
• Room category
• Nutrition support
• Expected hospital stay
• Follow-up consultations

Also ask about exclusions, including:

• Additional treatment cycles
• Treatment complications
• ICU admission
• Additional hospital days
• Additional medicines
• Blood products
• Donor-related expenses
• Repeat molecular testing
• Relapse treatment
• Treatment of unrelated medical conditions

Compare the Complete Treatment Cost

Australia: Treatment + Medicines + Hospital + Haematologist + Investigations + Rehabilitation + Follow-up

India: Treatment + Medicines + Hospital + Haematologist + Investigations + Flights + Accommodation + Visa + Insurance + Rehabilitation + Follow-up

Compare the full planned treatment journey, not only the treatment quotation.

Q3 · Which Indian Cities Are Best for Leukemia, Lymphoma and Blood Cancer Treatment for Australian Patients?

Australian patients can consider several established Indian healthcare destinations. The right city depends on the haematologist, haemato-oncology team, hospital, pathology and molecular facilities, transplant capability, cellular-therapy availability where required, supportive care, international-patient support and accessibility rather than simply the lowest treatment price.

The final city should be selected according to the patient's diagnosis, treatment requirements and

Q4 · Which Hospitals in India Should Australian Patients Consider for Blood Cancer Treatment?

The following hospitals are examples, not rankings or endorsements. Patients should confirm current haematology services, specialist availability, transplant capability, cellular-therapy services where relevant, hospital capability and suitability for the specific blood cancer.

What Should Australian Patients Check Before Choosing a Hospital?

• Who will manage the blood cancer treatment?
• Is the doctor a haematologist or haemato-oncology specialist?
• How experienced is the team with the patient's specific blood cancer?
• Does the hospital have dedicated haematology/oncology services?
• Is stem-cell transplantation available if required?
• Is a blood bank and transfusion support available 24/7?
• What pathology and molecular testing is available?
• Are chemotherapy, immunotherapy and targeted therapies available?
• Is CAR-T therapy available where clinically appropriate?
• What is included in the quotation?
• How long is the expected hospital stay?
• How are infections and treatment complications managed?
• What supportive care is available?
• What follow-up is available after returning to Australia?
• How will medical records be provided for follow-up in Australia?

Q5 · What Types of Leukemia, Lymphoma and Blood Cancer Treatments Are Available in India?

India offers a broad range of treatments for different blood cancers. The exact treatment depends on the diagnosis, disease classification, genetic and molecular findings, stage or risk group, age, general health and previous treatment.

a. Chemotherapy

Chemotherapy uses anti-cancer medicines to destroy or control abnormal blood cells. Treatment may involve combinations of medicines administered over multiple cycles.

b. Immunotherapy

Immunotherapy uses the patient's immune system or immune-directed medicines to target cancer cells. It may be used for selected leukemias, lymphomas and other blood cancers.

c. Targeted Therapy

Targeted medicines act against specific molecular or biological features of cancer cells. The suitability of targeted therapy depends on pathology and molecular testing.

d. Radiation Therapy

Radiation therapy may be used for selected lymphomas and other blood cancers, particularly where local disease control or symptom relief is required.

e. Autologous Stem Cell Transplantation

In an autologous transplant, the patient's own stem cells are collected and later returned following high-dose treatment. It may be considered for selected blood cancers.

f. Allogeneic Stem Cell Transplantation

An allogeneic transplant uses stem cells from a suitable donor. It may be considered for selected high-risk or relapsed blood cancers.

g. CAR-T Cell Therapy

CAR-T therapy genetically modifies a patient's T cells so they can recognise and attack specific cancer cells. It is used for selected blood cancers and requires specialist assessment and appropriate treatment facilities.

h. Combination and Relapsed/Advanced Blood Cancer Treatment

Patients with relapsed, refractory or high-risk disease may require combinations of chemotherapy, targeted therapy, immunotherapy, transplantation, cellular therapy or other specialist treatments.

The recommended treatment depends on the exact blood cancer diagnosis, pathology, molecular findings, disease status, previous treatment and multidisciplinary specialist assessment.

Q6 · How Can I Get a Blood Cancer Treatment Quotation From an Indian Hospital While I Am in Australia?

Australian patients can begin the process from home without travelling to India simply to obtain an initial treatment opinion and quotation.

You can submit:

• Complete blood-count reports
• Bone-marrow biopsy and aspirate reports
• Histopathology reports
• Flow-cytometry reports
• Cytogenetic/karyotype reports
• FISH results where applicable
• Molecular/genetic testing reports
• PET-CT/CT/MRI reports where relevant
• Lymph-node biopsy reports
• Previous chemotherapy records
• Previous immunotherapy or targeted-treatment records
• Stem-cell transplant records where applicable
• Blood-test reports
• Medication list
• Relevant medical history

The haematology team can review the records and provide a preliminary medical opinion. Once the treatment plan is established, the hospital can provide a cost estimate.

Ask for a Written Breakdown Covering

• Haematologist/oncologist fee
• Hospital charges
• Day-care or inpatient charges
• Chemotherapy medicines
• Immunotherapy/targeted medicines
• Pathology
• Molecular testing
• Imaging
• Blood and platelet transfusions
• Stem-cell collection where applicable
• Transplant charges where applicable
• ICU charges if required
• Room category
• Medicines
• Expected hospital stay
• Follow-up

Also ask about exclusions, including:

• Additional treatment cycles
• Treatment complications
• ICU admission
• Additional hospital days
• Additional medicines
• Blood products
• Donor-related expenses
• Additional molecular testing
• Relapse treatment
• Treatment of unrelated medical conditions

A detailed quotation allows Australian patients to compare hospitals based on total treatment value rather than simply the advertised treatment price.

Q7 · Should I Get a Second Blood Cancer Treatment Opinion From India Before Travelling From Australia?

A second opinion can be valuable if an Australian patient has already been diagnosed with leukemia, lymphoma or another blood cancer and wants to understand the diagnosis and possible treatment options.

You can send your existing:

• Blood reports
• Bone-marrow biopsy
• Flow-cytometry results
• Histopathology
• Cytogenetics
• Molecular testing
• PET-CT/CT/MRI reports where applicable
• Previous treatment records

An Indian haematologist or haemato-oncology specialist can provide an initial review and discuss whether chemotherapy, immunotherapy, targeted therapy, stem-cell transplantation, CAR-T therapy or another approach could be considered.

A Useful Second Opinion Should Address

• Exact blood cancer diagnosis
• Disease classification
• Stage or risk category where applicable
• Bone-marrow involvement where applicable
• Molecular and genetic findings
• Whether additional testing is required
• Recommended treatment
• Treatment sequence
• Number of expected treatment cycles
• Whether stem-cell transplantation should be considered
• Whether CAR-T therapy may be appropriate
• Expected hospital stay
• Potential complications
• Recovery requirements
• Recommended duration of stay in India

An online opinion is preliminary and does not replace a physical examination. The final treatment plan should be confirmed after the patient is assessed by the treating team.

Q8 · What Blood Cancer Treatment Options Are Available in India, and What Records Should an Australian Patient Take Home?

Blood cancer treatment may involve chemotherapy, immunotherapy, targeted therapy, radiation therapy, stem-cell transplantation or cellular therapy depending on the diagnosis.

The appropriate treatment depends on factors such as:

• Exact blood cancer type
• Disease classification
• Stage or risk group
• Bone-marrow involvement
• Lymph-node involvement
• Molecular findings
• Genetic abnormalities
• Previous treatment
• Treatment response
• Overall health
• Transplant eligibility
• Donor availability where applicable

Australian patients should not choose a treatment simply because it is newer or more expensive.

Ask why a particular treatment is recommended for the specific blood cancer.

Before Leaving India, Obtain

• Final diagnosis
• Complete pathology reports
• Bone-marrow biopsy reports
• Flow-cytometry reports
• Cytogenetic/karyotype results
• Molecular/genetic testing reports
• PET-CT/CT/MRI reports and images
• Treatment summary
• Chemotherapy records
• Immunotherapy/targeted-treatment records
• Transplant records where applicable
• CAR-T treatment records where applicable
• Discharge summary
• Medication list
• Follow-up plan
• Treating haematologist's contact information

Keep these records permanently with your Australian medical documents.

Q9 · Is Leukemia, Lymphoma and Blood Cancer Treatment in India Worth Considering for an Australian Patient?

Blood cancer treatment in India may be worth considering for an Australian patient when an experienced haematology team, appropriate cancer infrastructure and a clearly defined treatment and follow-up plan are available.

Potential reasons to consider India include:

• Access to experienced haematologists and haemato-oncologists
• Large multidisciplinary cancer centres
• Chemotherapy and immunotherapy services
• Targeted cancer treatments
• Stem-cell transplantation programmes
• Selected cellular therapies
• Advanced pathology and molecular testing
• Radiation oncology support
• Potentially lower private-treatment costs
• International-patient coordination

However, blood cancer treatment can require prolonged and closely monitored care.

The decision should consider:

• Exact cancer diagnosis
• Disease risk and stage
• Treatment urgency
• Specialist experience
• Hospital capability
• Infection-control facilities
• Blood-bank support
• Transplant/cellular therapy requirements
• Total treatment cost
• Travel requirements
• Long-term follow-up in Australia

Cost should therefore be considered alongside medical suitability, treatment quality and continuity of care.

Q10 · Will Australian Medicare or Travel Insurance Cover Leukemia, Lymphoma or Blood Cancer Treatment in India?

Australian patients should not assume that Medicare will pay for planned blood cancer treatment in India.

Australian Government travel guidance states that Medicare does not cover Australians for medical treatment overseas. Standard travel insurance also rarely covers medical tourism, so patients should investigate whether specialised insurance is available for the planned treatment and possible complications.

Before travelling, ask your insurer about:

• Planned cancer treatment
• Chemotherapy
• Immunotherapy
• Targeted therapy
• Stem-cell transplantation
• CAR-T therapy
• Pre-existing cancer
• Treatment complications
• Additional hospitalisation
• Medical evacuation
• Repatriation to Australia
• Flight changes caused by medical complications
• Accommodation if treatment is delayed Do not travel until you understand the policy exclusions.

Australian travellers should also be aware that medical care in India is generally payable by the patient and medical evacuation can be expensive.

Q11 · Can an Australian Patient Have Leukemia, Lymphoma or Blood Cancer Treatment During the Same Trip to India?

In some cases, diagnosis review, treatment planning and the initial phase of blood cancer treatment can be coordinated during the same trip. However, the exact treatment schedule depends on the diagnosis, treatment protocol and clinical response.

A treatment journey may include:

• Initial haematology consultation
• Review of pathology and bone-marrow results
• Additional diagnostic testing
• Molecular/genetic testing
• PET-CT or other imaging where required
• Multidisciplinary team review
• Treatment planning
• Chemotherapy
• Immunotherapy or targeted treatment
• Stem-cell collection where applicable
• Transplantation where applicable
• Supportive care
• Post-treatment review

Blood cancer treatment often involves multiple cycles or prolonged monitoring. A patient should not assume that the entire treatment course can be completed during one visit.

Australian patients should ask the hospital:

• How many weeks or months of treatment are expected?
• Will the patient need to remain in India between treatment cycles?
• Can some treatment be continued in Australia?
• What monitoring is required?
• When is it safe to fly?
• What happens if complications delay the return journey?

Do not plan flights based only on the first treatment date.

Q12 · What Are the Visa, Flight and Hospital Admission Steps for Blood Cancer Treatment in India?

Australian patients should organise the administrative side of treatment before travelling.

Step 1: Medical Review

Send blood reports, pathology, bone-marrow reports and imaging to the selected hospital.

Step 2: Specialist Opinion

Obtain a preliminary haematology/haemato-oncology opinion and proposed treatment plan.

Step 3: Cost Estimate

Request a written quotation covering the proposed treatment, medicines and expected hospitalisation.

Step 4: Hospital Confirmation

Confirm the treating specialist, treatment schedule, admission process and expected duration of stay.

Step 5: Visa

Check the current Indian visa requirements and apply through the official Indian visa system where eligible.

Step 6: Flights

Book flexible flights that allow sufficient time for consultations, investigations and treatment.

Step 7: Accommodation

Arrange suitable accommodation for the patient and accompanying family member.

Step 8: Admission

Complete hospital registration, investigations and treatment assessment after arrival.

Visa requirements, fees and document requirements can change, so Australian patients should verify current requirements before travelling.

Q13 · How Long Should an Australian Patient Stay in India During Blood Cancer Treatment?

The required stay can vary substantially depending on the type of blood cancer, treatment protocol, response to therapy and whether transplantation or cellular therapy is required.

The complete treatment journey may include:

• Pre-treatment consultation
• Diagnostic investigations
• Treatment planning
• Chemotherapy or other systemic treatment
• Hospital monitoring
• Blood/platelet transfusions where required
• Infection monitoring
• Stem-cell collection where applicable
• Transplantation where applicable
• Recovery
• Follow-up consultation
• Fitness-to-fly assessment
• Return to Australia

Patients undergoing intensive chemotherapy, transplantation or cellular therapy may require prolonged hospital or local accommodation arrangements.

Australian patients should avoid booking a rigid return date before the treating haematologist confirms that travel is medically appropriate.

The treating team should also advise about:

• Infection precautions
• Medication
• Blood-count monitoring
• Travel precautions
• Follow-up testing
• Emergency contact arrangements

Q14 · How Should an Australian Patient Plan Follow-Up Care After Returning Home?

Long-term blood cancer follow-up should be planned before leaving India.

Before discharge, ask the hospital for a complete set of medical records that can be shared with your Australian healthcare team.

Important Documents Include

• Discharge summary
• Complete treatment summary
• Pathology reports
• Bone-marrow reports
• Flow-cytometry reports
• Molecular/genetic testing
• Imaging reports and images
• Chemotherapy records
• Immunotherapy/targeted-treatment records
• Transplant records where applicable
• CAR-T records where applicable
• Medication list
• Blood-test schedule
• Follow-up schedule
• Treating haematologist's contact information

Before returning to Australia, arrange appropriate GP, haematologist/oncologist and other specialist follow-up as required.

Depending on the treatment, follow-up may include:

• Complete blood counts
• Bone-marrow assessment
• Molecular monitoring
• PET-CT or other imaging
• Monitoring for treatment complications
• Infection monitoring
• Medication management
• Transplant follow-up
• Long-term cancer surveillance

Establish how the Indian treating team can be contacted after returning to Australia.

A good international-patient pathway should provide continuity between the Indian treating team and Australian healthcare providers.

Q15 · Should I Have Leukemia, Lymphoma or Blood Cancer Treatment in Australia or Travel to India?

There is no single answer that applies to every Australian patient.

The decision should consider:

• Exact blood cancer diagnosis
• Disease stage or risk classification
• Treatment urgency
• Haematologist experience
• Hospital capability
• Total treatment cost
• Waiting time
• Insurance
• Travel requirements
• Treatment duration
• Rehabilitation/supportive care
• Long-term follow-up

Australia May Be Preferable When

• You have an established Australian haematology team
• Treatment can be provided within an acceptable timeframe
• You require continuous monitoring close to home
• You have suitable private health insurance
• Your preferred specialist and hospital are available locally
• You want treatment close to family
• You prefer easier access to Australian follow-up services
• Your insurance substantially reduces your personal expense

India May Be Worth Considering When

• You are medically suitable for international travel
• You have carefully researched the haematologist and hospital
• You have received a detailed treatment plan
• The required treatment is available
• Transplant or cellular-therapy capability is available if required
• The total cost remains attractive after adding travel and accommodation
• You want access to a particular specialist or treatment programme
• You have a clear follow-up plan for returning to Australia

Compare the Complete Treatment Cost

Australia: Treatment + Medicines + Hospital + Haematologist

India: Treatment + Medicines + Hospital + Haematologist